Full Length Research Paper
References
|
Abd El-Rahman SN, Al-Jameel SS (2014). Quercetin Nanoparticles: Preparation and Characterization. Indian J. Drugs 2(3):96-103. |
|
|
Abdelmoaty MA, Ibrahim MA, Ahmed NS, Abdelaziz MA (2010). Confirmatory studies on the antioxidant and antidiabetic effect of quercetin in rats. Indian J. Clin. Biochem. 25:188-192. |
|
|
Abolfathi AA, Mohajeri D, Rezaie A, Nazeri M (2012). Protective effects of green tea extract against hepatic tissue injury in streptozotocin-induced diabetic rats. Evid. Based Complement. Alternat. Med. Feb 21; 2012. |
|
|
Annapurna A, Reddy CS, Akondi, R.B, Rao SR (2009). Cardioprotective actions of two bioflavonoids, quercetin and rutin, in experimental myocardial infarction in both normal and streptozotocin-induced type I diabetic rats. J. Pharm. Pharmacol. 61(10):1365-1374. |
|
|
Arya A, Al-Obaidi MM, Shahid N, Bin Noordin MI, Looi CY, Wong WF, Khaing SL, Mustafa MR (2014). Synergistic effect of quercetin and quinic acid by alleviating structural degeneration in the liver, kidney and pancreas tissues of STZ-induced diabetic rats: A mechanistic study. Food Chem. Toxicol. 71:183-196. |
|
|
Ayodele OE, Alebiosu CO, Salako BL (2004). Diabetic nephropathy, a review of the natural history, burden, risk factors and treatment. J. Natl. Med. Assoc. 96:1445-1454. |
|
|
Babujanarthanam B, Kavitha P, MahadevaRao US, Pandian MR (2011). Quercitrin a bioflavonoid improves the antioxidant status in streptozotocin: induced diabetic rat tissues. Mol. Cell. Biochem. 358:121-129. |
|
|
Babujanarthanam R, Kavitha P, Rajasekara PM (2010). Quercitrin, a bioflavonoid improves glucose homeostasis in streptozotocin-induced diabetic tissues by altering glycolytic and gluconeogenic enzymes. Fundam. Clin. Pharmacol. 24:357-364. |
|
|
Bala I, Bhardwaj V, Hariharan S, Kharade SV, Roy N, Ravi Kumar MN (2006). Sustained release nanoparticulate formulation containing antioxidant ellagic acid as potential prophylaxis system for oral administration. J. Drug Target. 14:27-34. |
|
|
Bashir SO, Morsy MD, Sakr HF, El Refaey HM, Eid RA, Alkhateeb MA, Defallah MA (2014). Quercetin ameliorates diabetic nephropathy in rats via modulation of renal Na+, K+ -ATPase expression and oxidative stress. Am. J. Pharmacol. Toxicol. 9:84-95. |
|
|
Bilati U, Allemann E, Doelker E (2005). Development of a nano precipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Euro. J. Pharm. Sci. 24:67-75. |
|
|
Boots AW, Haenen GR, Bast A (2008). Health effects of quercetin: from antioxidant to nutraceutical. Euro. J. Pharmacol. 585:325-337. |
|
|
Candlish JK, Das NP (1996). Antioxidants in food and chronic degenerative diseases. Biomed. Environ. Sci. 9:117-123. |
|
|
Ceriello A (2000). Oxidative stress and glycemic regulation. Metabolism 49:27s-29s. |
|
|
Chang CC, Chang CY, Huang JP, Hung LM (2012). Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats. Chin. J. Physiol. 55:192-201. |
|
|
Chen S, Cohen MP, Lautenslager GT, Shearman CW, Ziyadeh FN (2001). Glycated albumin stimulates TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells. Kidney Int. 59:673-681. |
|
|
Coldiron AD, Sanders RA, Watkins JB (2002). Effects of combined quercetin and coenzyme Q10 treatment on oxidative stress in normal and diabetic rats. J. Biochem. Mol. Toxicol. 16(4):197-202. |
|
|
Coskun O, Ocakcı A, Bayraktaroglu T, Kanter M (2004). Exercise training prevents and protects streptozotocin-induced oxidative stress and -cell damage in rat pancreas. Tohoku J. Exp. Med. 203:145-154. |
|
|
Dias AS, Porawski M, Alonso M, Marroni N, Collado PS, González-gallego J (2005). Quercetin decreases oxidative stress, NF-B activation, and iNOS overexpression in liver of streptozotocin induced diabetic rats. J. Nutr. 135:2299-2304. |
|
|
Dominguez C, Ruiz E, Gussinye M, Carrascosa A (1998). Oxidative stress at onset and in early stages of type I diabetes in children and adolescents. Diabetes Care 21:1736-1742. |
|
|
Donath MY, Shoelson SE (2011). Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol.11:98-107. |
|
|
Eddy AA (1996). Experimental insights into the tubule interstitial disease accompanying primary glomerular lesions. J. Am. Soc. Nephrol. 7:2494-2508. |
|
|
Edremitlioglu M, Andic MF, Korkut O (2012). Quercetin, a powerful antioxidant bioflavonoid, prevents oxidative damage in different tissues of long-term diabetic rats. Balkan Med. J. 29:49-55. |
|
|
Elbe H, Esrefoglu M, Vardi N, Taslidere E, Ozero E, Tanbek K (2015). Melatonin, quercetin and resveratrol attenuate oxidative hepatocellular injury in streptozotocin-induced diabetic rats. Hum. Exp. Toxicol. 34:859-868. |
|
|
Feliers D, Duraisamy S, Faulkner JL, Duch J, Lee AV, Abboud HE (2001). Activation of renal signaling pathways in db/db mice with type 2 diabetes. Kidney Int. 60:495-504. |
|
|
Ferrali M, Signofrini C, Caciotti B, Sugherini L, Ciccoli D, Giachetti D, Comporti M (1997). Protection against oxidative damage of erythrocyte membranes by the flavonoid quercetin and its relation to iron chelating activity. FEBS Lett. 416:123-139. |
|
|
Flohé FL, Günzler WA (1984). Assays of glutathione peroxidase. Methods Enzymol.105:114-1121. |
|
|
Formica JV, Regelson W (1995). Review of the biology of quercetin and related bioflavonoids. Food. Chem. Toxicol. 33:1061-1080. |
|
|
Gutterer JM, Dringen R, Hirrlinger J, Hamprecht B (1999). Purification of glutathione reductase from bovine brain, generation of an antiserum, and immune cytochemical localization of the enzyme in neural cells. J. Neurochem. 73(4):1422-1430. |
|
|
Hamadi N, Mansour A, Hassan MH, Khalifi-Touhami F, Badary O (2012). Ameliorative effects of resveratrol on liver injury in streptozotocin-induced diabetic rats. J. Biochem. Mol. Toxicol. 26:384-392. |
|
|
Hii CS, Howell SL (1985a). Effects of epicatechin on rat islets of Langerhans. Diabetes 33:291-296. |
|
|
Hii CST, Howell SL (1985b). Effects of flavanoids on insulin secretion and 45Ca2+ handling in rat islets of langerhans. J. Endocrinol. 107:1-8. |
|
|
Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH (2009). Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes 58:1668-1671. |
|
|
Hsu CH, Cui Z, Mumper RJ, Jay M (2003). Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. AAPS PharmSciTech. 4(3):24-35. |
|
|
Jeong SM, Kang MJ, Choi HN, Kim JH, Kim JI (2012). Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice. Nutr. Res. Pract. 6(3):201-207. |
|
|
Josephy PD (1997). Molecular toxicology. New York: Oxford University Press. |
|
|
Kakran M, Sahoo NG, Li L, Judeh Z (2012). Fabrication of quercetin nanoparticles by anti-solvent precipitation method for enhanced dissolution. Powder Technol. 223:59-64. |
|
|
Kandasamy N, Ashokkumar N (2012). Myricetin, a natural flavonoid, normalizes hyperglycemia in streptozotocin-cadmium-induced experimental diabetic nephrotoxic rats. Biomed. Prev. Nutr. 2:246-251. |
|
|
Kanter M, Coskun O, Korkmaz A, Oter S (2004). Effects of Nigella sativa on oxidative stress and -cell damage in streptozotocin-induced diabetic rats. Anat. Rec. 279:685-691. |
|
|
Kiviranta J, Huovinen K, Hiltunen R (1998). Variation of phenolic substances in onion. Acta Pharm. Fenn. 97:67-72. |
|
|
Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B (1991). Inhibition of mammalian5-lipoxygenaseandcyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem. Pharmacol. 42:1673-1681. |
|
|
Lu Q, Yın XX, Wang JY, Gao YY, Pan YM (2007). Effects of Ginkgo biloba on prevention of development of experimental diabetic nephropathy in rats. Acta Pharmacol. Sin. 28:818-828. |
|
|
Maciel RM, Costa MM, Martins DB, França RT, Schmatz R, Graça DL, Duarte MM, Danesi CC, Mazzanti CM, Schetinger MRC, Paim FC, Palma HE, Abdala FH, Stefanello N, Zimpel CK, Felin DV, Lopes STA (2013). Antioxidant and anti-inflammatory effects of quercetin in functional and morphological alterations in streptozotocin-induced diabetic rats. Res. Vet. Sci. 95:389-397. |
|
|
Maritim AC, Moore BH, Sanders RA, Watkins JB (1991). Effects of melatonin on oxidative stress in streptozicin-induced diabetic rats. Int. J. Toxicol. 18:61-166. |
|
|
Maritim AC, Sanders RA, Watkins JB (2003). Effects of a-lipoic acid on biomarkers of oxidative stress in streptozotocin induced diabetic rats. J. Nutr. Biochem. 14:288-294. |
|
|
Meister A (1988). Glutathione metabolism and its selective modiï¬cation. J. Biol. Chem. 263:17205-17208. |
|
|
Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C (1998). Plasma metabolites of quercetin and their antioxidant properties. Am. J. Physiol. 275:R212-R219. |
|
|
Mulholland PJ, Ferry DR, Anderson D, Hussain SA, Young AM, Cook JE, Hodgkin E, Seymour LW, Kerr DJ (2001). Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Ann. Oncol. 12:245-248. |
|
|
Murea M, Freedman BI, Parks JS, Antinozzi PA, Elbein SC, Ma L (2010). Lipotoxicity in diabetic nephropathy: the potential role of fatty acid oxidation. Clin. J. Am. Soc. Nephrol. 5:2373-2379. |
|
|
Nagasawa HT, Cohen JF, Holleschau AM, Rathbun WB (1996). Augmentation of human and rat lenticular glutathione in vitro by prodrugs of c-l-glutamyl-l-cysteine. J. Med Chem. 39:1676-1681. |
|
|
Naoum PC (1999). Eletroforese – Técnicas e diagnósticos. 2ed. Livraria. Santos. Editora. |
|
|
Natarajan R, Gerrity RG, Gu JL, Lanting L, Thomas L, Nadler JL (2002). Role of 12lipoxygenase and oxidant stress in hyperglycaemia-induced acceleration of atherosclerosis in a diabetic pig model. Diabetologia 45:125-133. |
|
|
Plumb GW, Price KR, Williamson G (1999). Antioxidant properties of flavonol glycosides from green beans. Redox Rep. 4:123-127. |
|
|
Reddy MA, Thimmalapura PR, Lanting L, Nadler JL, Fatima S, Natarajan R (2002). The oxidized lipid and lipoxygenase product 12(S)-hydroxyeicosatetraenoic acid induces hypertrophy and fibronectin transcription in vascular smooth muscle cells via p38 MAPK and cAMP response element-binding protein activation. Mediation of angiotensin II effects. J. Biol. Chem. 277:9920-9928. |
|
|
Report of WHO study group on Diabetes Mellitus (1985). WHO Technol. Re. Ser. 727:1-113. |
|
|
Rice-Evans CA, Miller NJ, Paganga G (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 20:933-956. |
|
|
Robak J, Gryglewski RJ (1988). Flavonoids are scavengers of superoxide anions. Biochem. Pharmacol. 37:837-841. |
|
|
Saxena AK, Srivastava P, Kale RK, Baquer NZ (1993). Impaired antioxidant status in rat liver – effect of vanadate. Biochem. Pharmacol. 45:539-542. |
|
|
Schermer S (1967). The Blood Morphology of Laboratory Animal Longmans, Green and Co. Ltd, P. 350. |
|
|
Sen CK (1997). Nutritional biochemistry of cellular glutathione. J. Nutr. Biochem. 8:660-672. |
|
|
Sinha KA (1972). Colorimetric assay of catalase. Ann. Biochem. 47:389-394. |
|
|
Sirovina D, Orsolic N, Koncic MZ, Kovacevic G, Benkovic V, Gregorovic G (2013). Quercetin vs chrysin: effect on liver histopathology in diabetic mice. Hum. Exp. Toxicol. 32:1058-1066. |
|
|
Stanley MPP, Menon VP (2001). Antioxidant action of Tinosporacordifolia root extract in alloxan diabetic rats. Phytother. Res.15:213-218 |
|
|
Tatsuki R, Satoh K, Yamamoto A, Hoshi K, Ichihara K (1997). Lipid peroxidation in the pancreas and other organs in streptozotocin diabetic rats. Jpn. J. Pharmacol. 75:267-273. |
|
|
Tone A, Shikata K, Sasaki M, Ohga S, Yozai K, Nishishita S, Usui H, Nagase R, Ogawa D, Okada S, Shikata Y, Wada J, Makino H (2005). Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats. Diabetologia 48:2402-2411. |
|
|
Tsao TS, Stenbit AE, Factor SM, Chen W, Rossetti L, Charron MJ (1999). Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle. Diabetes 48:775-782. |
|
|
Un J, Mi-Kyung L, Yong B, Mi A, Myung-Sook C (2006). Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int. J. Biochem. Cell. Biol. 38:1134-1145. |
|
|
Vardi N, Ucar M, Iraz M, Ozturk F (2003). Morphological changes of rat endocrine pancreas in experimental diabetes. T. Klin. J. Med. Sci. 23:27-32. |
|
|
Vessal M, Hemmati M, Vasei M (2003). Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 135:357-364. |
|
|
Voziyan PA, Metz TO, Baynes JW, Hudson BG (2002). A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation. J. Biol. Chem. 277:3397-3403. |
|
|
Walsh CM, Aleo MD (1997). Mechanistic analysis of S(1,2-dichlorovinyl)-l-cysteine- induced cataractogenesis in vitro. Toxicol Appl. Pharmacol.146:144-155. |
|
|
Weisburer JH (2000). Approaches for chronic disease prevention based on current understanding of underlying mechanisms. Am. J. Clin. Nutr. 71:1710s-1719s. |
|
|
Yanardag R, Ozsoy-Sacan O, Bolkent S, Orak H, Karabulut-Bulan O (2005). Protective effects of metformin treatment on the liver injury of streptozotocin-diabetic rats. Hum. Exp. Toxicol. 24:129-135. |
|
|
Yen FL, Wu TH, Lin LT, Cham TM, Lin CC (2009). Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl4-induced acute liver failure. Pharm. Res. 26:893-902. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
